Cite
HARVARD Citation
Kharidia, J. et al. (2021). Evaluation of Drug‐Drug Interaction Liability for Buprenorphine Extended‐Release Monthly Injection Administered by Subcutaneous Route. Clinical pharmacology in drug development. 10 (9), pp. 1064-1074. [Online].